4647 Superior Street
Director of Marketing/Communications
CATEGORIES & HEADINGSdetails >>
For more than 39 years, LI-COR Biosciences has been a global leader in the environmental and life science fields. LI-COR instruments, software and reagents are used by researchers in more than 100 countries in studies ranging from climate change to cancer research.
LI-CORs Odyssey® family of imagers has become the standard for quantitative infrared fluorescent detection in the life science field. Many scientific disciplines use Odyssey technology for a wide range of applications, including Western blots, gel shift assays, protein arrays, RNAi screening, small animal imaging and plate-based assays, such as LI-CORS novel In-Cell Western? assay.
The Odyssey Fc Imaging System allows labs to obtain superior Western blot detection with both chemiluminescence and infrared fluorescence on one easy-to-use system.
The Pearl® Impulse Small Animal Imaging System gives scientists the ability to track biological events and disease progression in living animals. Along with BrightSite? optical probes, the Pearl can provide valuable information for many areas of research, including apoptosis, angiogenesis, inflammation, bone growth, cell signaling, and many others. These near-infrared fluorescent probes are used for targeting tumors, bone, lymphatics, and more, and can be used on any infrared imaging system.
LI-COR also develops and manufactures a diverse line of infrared reagents that improves the reliability, accuracy and performance of all applications supported by LI-COR systems.
The Clinical Translation group at LI-COR facilitates the use of its IRDye® 800CW labeled imaging agents in clinical studies for detection of disease, its progression, and for monitoring treatment and drug efficacy.
In addition to its headquarters in Lincoln, Nebraska, LI-COR has subsidiary offices in Bad Homburg, Germany and Cambridge, United Kingdom. LI-COR is a privately held company and is ISO 9001:2008 certified.